This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Novel Therapy of PAD by Combined Transplantation of BMCs

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified December 2006 by Heinrich-Heine University, Duesseldorf.
Recruitment status was:  Recruiting
Information provided by:
Heinrich-Heine University, Duesseldorf Identifier:
First received: December 13, 2006
Last updated: NA
Last verified: December 2006
History: No changes posted

We analyze the effects of combined intramuscular and intraarterial transplantation of BMCs in patients with PAD. BMCs were transplanted into the ischemic limb.

After 2 and 13 months walking distance and perfusion indices were monitored.

Condition Intervention Phase
Peripheral Arterial Disease Procedure: intraarterial and intramuscular injection of BMCs Phase 1

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Transplantation of Autologous Mononuclear Bone Marrow Stem Cells in Patients With Peripheral Arterial Disease (TAM-PAD Study)

Resource links provided by NLM:

Further study details as provided by Heinrich-Heine University, Duesseldorf:

Primary Outcome Measures:
  • ABI, walking distance, capillary-venous oxygen saturation, venous occlusion plethysmography

Secondary Outcome Measures:
  • feasibility

Estimated Enrollment: 100
Study Start Date: July 2004

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • severe limb ischemia

Exclusion Criteria:

  • infectious disease
  • cancer
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00411840

Contact: Thomas Bartsch, MD +492118118800

Heinrich-Heine-University Recruiting
Duesseldorf, Germany, 40225
Contact: Bodo E Strauer, MD    +492118118801   
Principal Investigator: Thomas Bartsch, MD         
Sponsors and Collaborators
Heinrich-Heine University, Duesseldorf
Study Director: Bodo E Strauer, MD Heinrich-Heine University, Duesseldorf
  More Information Identifier: NCT00411840     History of Changes
Other Study ID Numbers: TAM-PAD
Study First Received: December 13, 2006
Last Updated: December 13, 2006

Keywords provided by Heinrich-Heine University, Duesseldorf:
stem cell therapy
peripheral arterial disease
limb ischemia

Additional relevant MeSH terms:
Peripheral Arterial Disease
Peripheral Vascular Diseases
Arterial Occlusive Diseases
Vascular Diseases
Cardiovascular Diseases processed this record on September 19, 2017